Home530239 • BOM
Suven Life Sciences Ltd
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 14.67M | -38.50% |
Operating expense | 454.80M | 37.22% |
Net income | -439.45M | -65.58% |
Net profit margin | -3.00K | -169.22% |
Earnings per share | — | — |
EBITDA | -434.44M | -44.17% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 600.05M | -74.98% |
Total assets | 1.35B | -52.55% |
Total liabilities | 251.97M | 69.53% |
Total equity | 1.10B | — |
Shares outstanding | 218.07M | — |
Price to book | 49.66 | — |
Return on assets | — | — |
Return on capital | -73.89% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -439.45M | -65.58% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
₹250.30
Day range
₹237.80 - ₹249.70
Year range
₹102.70 - ₹303.00
Market cap
54.20B INR
Avg Volume
22.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NSE
About
Founded
1989
Website
Employees
138
